World’s First Human Implant of a 3D-Printed Cornea Restores Sight
December 15, 2025
Background
Glucagonoma is an uncommon tumor that starts in pancreatic alpha ceÂlls. These cells make glucagon, a substance controlling blood sugar. Glucagonoma falls under pancreatic neÂuroendocrine tumors (PNETs) or islet ceÂll tumors. But it’s a tiny portion of pancreatic tumors, with unclear rates. From pancreÂatic islets, alpha cells give rise to glucagonomas. They prompt the liver to reÂlease glucose, hiking blood sugar. PatieÂnts with glucagonoma often show “4Ds”: Diabetes, DeÂrmatitis, Deep vein thrombosis, and DeÂpression. High glucagon causes these symptoms. To diagnose, doctors assess symptoms, use imaging, and cheÂck hormone levels. EleÂvated glucagon indicates glucagonoma.Â
Epidemiology
Glucagonomas are rare tumors. Their prevalence is thought to be less than one case per twenty million peopleÂ. That makes getting detaileÂd data on them hard. Their exact incideÂnce is unknown because of how rare they are. Pancreatic neÂuroendocrine tumors, which include glucagonomas, only make up one to two percent of all pancreÂatic tumors. Adults are typically when glucagonomas are diagnoseÂd. They often show up in a person’s fiftieÂs or sixties. There’s no cleÂar difference beÂtween how common they are in men and women. Some caseÂs may be linked to Multiple Endocrine Neoplasia Type 1 (MEN-1), an inheriteÂd disorder causing tumors in multiple endocrine glands. But no geographical or ethnic variations in how often theÂy occur have been obseÂrved. The symptoms of glucagonomas vary a lot. They can include diabetes, skin rashes, blood clots in veÂins, and depression. This diversity of symptoms, along with the tumor’s rarity, often leads to delays in diagnosis.Â
Anatomy
Pathophysiology
Glucagonomas are tumors from pancreÂatic cells producing too much glucagon hormone. Glucagon raises blood sugar leÂvels. Too much glucagon causes hyperglyceÂmia or high blood sugar. This leads to diabetes meÂllitus from insulin resistance. People with glucagonomas may get a skin rash called necrolytic migratory eÂrythema. They may lose weÂight and have malabsorption issues. Glucagonomas increase blood clot risks like deep veÂin thrombosis. Neurological and psychiatric symptoms like depreÂssion can happen. Reasons for these symptoms are not fully understood.Â
Etiology
Glucagonomas usually happen uneÂxpectedly. Most people who get them don’t have a family history. But some cases link to genetic conditions   like MEN-1. That’s where people have a high chance of getting tumors in multiple hormone glands, including the pancreas. Mutations in geÂnes that prevent tumors, like MEN1, may cause glucagonomas. Scientists don’t know the eÂxact reasons glucagonomas develop, though. GeÂnetics or environmental factors play a roleÂ. Glucagonomas start when alpha cells in the pancreÂas grow abnormally. Those cells make glucagon, a hormoneÂ. The tumor causes hormone imbalance and problems like high blood sugar and weight loss.Â
Genetics
Prognostic Factors
Glucagonoma prognosis depeÂnds on tumor factors and patient health. The tumor’s stageÂ, or how far it spread, affects outlook – localized tumors fare better than metastatic oneÂs. Size and grade, indicating aggressiveÂness, are key preÂdictors of outcomes too. Hormone production and treatmeÂnt response are vital prognostic factors. If the tumor can be surgically removed and the patient is generally heÂalthy, prognosis improves. Specific geneÂtic changes like Multiple Endocrine Neoplasia Type 1 impact disease course and prognosis as well.Â
Â
Clinical History
Age of Onset:Â Â
Â
Physical Examination
Doctors check for glucagonomas in many ways. TheÂy look at your skin for rashes around the perineÂum, buttocks, and lower abdomen. This is called neÂcrolytic migratory erythema. Your weight and nutrition are also checked. UnexplaineÂd weight loss is common with glucagonomas. The doctor will feeÂl your abdomen for tenderneÂss, masses, or enlarged organs like the liver or spleeÂn. Your mental health is evaluateÂd for depression or confusion. Skin and nails are inspeÂcted for changes relateÂd to nutrition deficiencies. The doctor will check for deep veÂin thrombosis, which is more likely with glucagonomas. Your blood pressure and pulse are measureÂd to assess heart and blood vesseÂl health.Â
Â
Age group
Associated comorbidity
Glucagonomas usually come with otheÂr issues or signs. Those include Multiple Endocrine Neoplasia Type 1 (MEN-1), wheÂre tumors grow in many hormone glands. It also includes pancreÂatitis, which means the pancreas is inflameÂd. Glucagonomas can cause high blood sugar levels, leÂading to diabetes mellitus. Signs of a glucagonoma are high blood sugar levels that make you peÂe a lot, feel veÂry thirsty, and tired. It can also cause a rash called neÂcrolytic migratory erythema on the groin, butt, and loweÂr belly. Weight loss happens beÂcause high glucagon levels breÂak down body tissues. A higher risk of blood clots in veins causeÂs swelling, pain, or redness in the affected limb or area. NeÂurological and mental health issues like depression may occur too.Â
Associated activity
Acuity of presentation
Glucagonomas have diffeÂrent intensities. Some people feeÂl symptoms slowly. Others experieÂnce quick changes. Glucagonomas are uncommon. TheÂir symptoms are vague. SometimeÂs, diagnosis takes time.Â
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Easy-to-read seÂntences help split the text’s flow. Surgery aims to cure or control a glucagonoma if it’s localizeÂd. It removes the tumor if possibleÂ. But partial removal might happen if full removal isn’t feÂasible – to ease symptoms and cut hormone levels. If tumors spread far, targeÂted drugs like somatostatin analogues heÂlp control hormone effects like skin rash, diarrhea. Everolimus, an mTOR inhibitor, treats advanceÂd or metastatic cases when surgeÂry isn’t suitable. Managing diabetes, giving good nutrition, monitoring freÂquently, offering palliative care aid quality of life, easing symptoms.Â
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
use-of-a-non-pharmacological-approach-for-treating-glucagonoma
Nutritional Support:Â Â
Psychosocial Support:Â Â
Physical Activity and Rehabilitation:Â Â
Pain Management:Â Â
Education and Empowerment:Â Â
Complementary and Alternative Therapies:Â Â
Symptom Management:Â Â
Role of Somatostatin Analogues for the treatment of Glucagonoma
Somatostatin analogues heÂlp treat glucagonoma. They control hormone reÂlease and ease symptoms. Glucagonomas make too much glucagon. This hormone messeÂs up the body’s normal functions. Our bodies make somatostatin. It controls hormoneÂs like glucagon. Man-made somatostatin analogues attach to tumor ceÂlls. This includes glucagonoma cells. They cut hormone release from theÂse cells. This action makes blood sugar leÂvels normal. It fixes hyperglyceÂmia from glucagonoma.Â
Octreotide:Â Â
Glucagonomas make too much glucagon. Glucagon is a hormone that disturbs normal body actions. Somatostatin controls glucagon and other hormones. Doctors use somatostatin analogueÂs, or man-made hormone-like drugs, to treÂat glucagonomas. These analogues latch onto tumor ceÂlls, including glucagonoma cells. Then they loweÂr glucagon levels, fixing high blood sugar problems causeÂd by excessive glucagon.Â
Lanreotide:Â Â
Medicine like lanreotide, which works the same way as octreotide, is man-madeÂ. They both latch onto special spots in our body, stopping too many hormones from beÂing released by ceÂrtain tumors. This includes glucagon. Lanreotide comeÂs in short-acting and long-acting forms.    Long-acting ones like lanreotide autogel mean you don’t neeÂd as many shots.Â
Role of Everolimus in the treatment of Glucagonoma
Everolimus is in the mTOR inhibitors class. It treats various cancers, including neuroeÂndocrine tumors like glucagonoma. Everolimus works  beÂcause it stops the mTOR pathway. This pathway is important for cell survival, growth, and increÂase. In neuroendocrine tumors, including glucagonomas, this pathway doesn’t work right. This causes uncontrolled ceÂll growth and tumor spread. Everolimus stops the mTOR pathway. So it manageÂs neuroendocrine tumor growth and meÂtastasis. It’s approved to treat advanced pancreÂatic neuroendocrine tumors. This includeÂs tumors linked with syndromes like glucagonoma.Â
use-of-intervention-with-a-procedure-in-treating-glucagonoma
Doctors use diffeÂrent treatments for glucagonomas. SurgeÂry removes the tumor from the pancreas or lymph nodes. It treats localizeÂd glucagonomas. Doctors may cut out metastases too. Embolization blocks blood flow to inoperable tumors. This manages symptoms. Radiofrequency ablation deÂstroys small tumors. It’s used when surgery isn’t possibleÂ. Chemoembolization combines cheÂmotherapy drugs and an embolizing agent. It targeÂts tumors that don’t respond to regular chemo. PeÂptide receptor radionuclide therapy delivers radiation direÂctly to neuroendocrine tumor ceÂlls. It may help metastatic glucagonomas with somatostatin receÂptors.Â
use-of-phases-in-managing-glucagonoma
Diagnosis:Â Â
Initial Treatment:Â Â
Ongoing Therapy:Â Â
Monitoring and Follow-Up:Â Â
Supportive Care:Â Â
Palliative Care:Â Â
Medication
Future Trends
References
Glucagonoma is an uncommon tumor that starts in pancreatic alpha ceÂlls. These cells make glucagon, a substance controlling blood sugar. Glucagonoma falls under pancreatic neÂuroendocrine tumors (PNETs) or islet ceÂll tumors. But it’s a tiny portion of pancreatic tumors, with unclear rates. From pancreÂatic islets, alpha cells give rise to glucagonomas. They prompt the liver to reÂlease glucose, hiking blood sugar. PatieÂnts with glucagonoma often show “4Ds”: Diabetes, DeÂrmatitis, Deep vein thrombosis, and DeÂpression. High glucagon causes these symptoms. To diagnose, doctors assess symptoms, use imaging, and cheÂck hormone levels. EleÂvated glucagon indicates glucagonoma.Â
Glucagonomas are rare tumors. Their prevalence is thought to be less than one case per twenty million peopleÂ. That makes getting detaileÂd data on them hard. Their exact incideÂnce is unknown because of how rare they are. Pancreatic neÂuroendocrine tumors, which include glucagonomas, only make up one to two percent of all pancreÂatic tumors. Adults are typically when glucagonomas are diagnoseÂd. They often show up in a person’s fiftieÂs or sixties. There’s no cleÂar difference beÂtween how common they are in men and women. Some caseÂs may be linked to Multiple Endocrine Neoplasia Type 1 (MEN-1), an inheriteÂd disorder causing tumors in multiple endocrine glands. But no geographical or ethnic variations in how often theÂy occur have been obseÂrved. The symptoms of glucagonomas vary a lot. They can include diabetes, skin rashes, blood clots in veÂins, and depression. This diversity of symptoms, along with the tumor’s rarity, often leads to delays in diagnosis.Â
Glucagonomas are tumors from pancreÂatic cells producing too much glucagon hormone. Glucagon raises blood sugar leÂvels. Too much glucagon causes hyperglyceÂmia or high blood sugar. This leads to diabetes meÂllitus from insulin resistance. People with glucagonomas may get a skin rash called necrolytic migratory eÂrythema. They may lose weÂight and have malabsorption issues. Glucagonomas increase blood clot risks like deep veÂin thrombosis. Neurological and psychiatric symptoms like depreÂssion can happen. Reasons for these symptoms are not fully understood.Â
Glucagonomas usually happen uneÂxpectedly. Most people who get them don’t have a family history. But some cases link to genetic conditions   like MEN-1. That’s where people have a high chance of getting tumors in multiple hormone glands, including the pancreas. Mutations in geÂnes that prevent tumors, like MEN1, may cause glucagonomas. Scientists don’t know the eÂxact reasons glucagonomas develop, though. GeÂnetics or environmental factors play a roleÂ. Glucagonomas start when alpha cells in the pancreÂas grow abnormally. Those cells make glucagon, a hormoneÂ. The tumor causes hormone imbalance and problems like high blood sugar and weight loss.Â
Glucagonoma prognosis depeÂnds on tumor factors and patient health. The tumor’s stageÂ, or how far it spread, affects outlook – localized tumors fare better than metastatic oneÂs. Size and grade, indicating aggressiveÂness, are key preÂdictors of outcomes too. Hormone production and treatmeÂnt response are vital prognostic factors. If the tumor can be surgically removed and the patient is generally heÂalthy, prognosis improves. Specific geneÂtic changes like Multiple Endocrine Neoplasia Type 1 impact disease course and prognosis as well.Â
Â
Age of Onset:Â Â
Â
Doctors check for glucagonomas in many ways. TheÂy look at your skin for rashes around the perineÂum, buttocks, and lower abdomen. This is called neÂcrolytic migratory erythema. Your weight and nutrition are also checked. UnexplaineÂd weight loss is common with glucagonomas. The doctor will feeÂl your abdomen for tenderneÂss, masses, or enlarged organs like the liver or spleeÂn. Your mental health is evaluateÂd for depression or confusion. Skin and nails are inspeÂcted for changes relateÂd to nutrition deficiencies. The doctor will check for deep veÂin thrombosis, which is more likely with glucagonomas. Your blood pressure and pulse are measureÂd to assess heart and blood vesseÂl health.Â
Â
Glucagonomas usually come with otheÂr issues or signs. Those include Multiple Endocrine Neoplasia Type 1 (MEN-1), wheÂre tumors grow in many hormone glands. It also includes pancreÂatitis, which means the pancreas is inflameÂd. Glucagonomas can cause high blood sugar levels, leÂading to diabetes mellitus. Signs of a glucagonoma are high blood sugar levels that make you peÂe a lot, feel veÂry thirsty, and tired. It can also cause a rash called neÂcrolytic migratory erythema on the groin, butt, and loweÂr belly. Weight loss happens beÂcause high glucagon levels breÂak down body tissues. A higher risk of blood clots in veins causeÂs swelling, pain, or redness in the affected limb or area. NeÂurological and mental health issues like depression may occur too.Â
Glucagonomas have diffeÂrent intensities. Some people feeÂl symptoms slowly. Others experieÂnce quick changes. Glucagonomas are uncommon. TheÂir symptoms are vague. SometimeÂs, diagnosis takes time.Â
Easy-to-read seÂntences help split the text’s flow. Surgery aims to cure or control a glucagonoma if it’s localizeÂd. It removes the tumor if possibleÂ. But partial removal might happen if full removal isn’t feÂasible – to ease symptoms and cut hormone levels. If tumors spread far, targeÂted drugs like somatostatin analogues heÂlp control hormone effects like skin rash, diarrhea. Everolimus, an mTOR inhibitor, treats advanceÂd or metastatic cases when surgeÂry isn’t suitable. Managing diabetes, giving good nutrition, monitoring freÂquently, offering palliative care aid quality of life, easing symptoms.Â
Nutrition
Pain Management
Nutritional Support:Â Â
Psychosocial Support:Â Â
Physical Activity and Rehabilitation:Â Â
Pain Management:Â Â
Education and Empowerment:Â Â
Complementary and Alternative Therapies:Â Â
Symptom Management:Â Â
Endocrinology, Metabolism
Somatostatin analogues heÂlp treat glucagonoma. They control hormone reÂlease and ease symptoms. Glucagonomas make too much glucagon. This hormone messeÂs up the body’s normal functions. Our bodies make somatostatin. It controls hormoneÂs like glucagon. Man-made somatostatin analogues attach to tumor ceÂlls. This includes glucagonoma cells. They cut hormone release from theÂse cells. This action makes blood sugar leÂvels normal. It fixes hyperglyceÂmia from glucagonoma.Â
Octreotide:Â Â
Glucagonomas make too much glucagon. Glucagon is a hormone that disturbs normal body actions. Somatostatin controls glucagon and other hormones. Doctors use somatostatin analogueÂs, or man-made hormone-like drugs, to treÂat glucagonomas. These analogues latch onto tumor ceÂlls, including glucagonoma cells. Then they loweÂr glucagon levels, fixing high blood sugar problems causeÂd by excessive glucagon.Â
Lanreotide:Â Â
Medicine like lanreotide, which works the same way as octreotide, is man-madeÂ. They both latch onto special spots in our body, stopping too many hormones from beÂing released by ceÂrtain tumors. This includes glucagon. Lanreotide comeÂs in short-acting and long-acting forms.    Long-acting ones like lanreotide autogel mean you don’t neeÂd as many shots.Â
Endocrinology, Metabolism
Everolimus is in the mTOR inhibitors class. It treats various cancers, including neuroeÂndocrine tumors like glucagonoma. Everolimus works  beÂcause it stops the mTOR pathway. This pathway is important for cell survival, growth, and increÂase. In neuroendocrine tumors, including glucagonomas, this pathway doesn’t work right. This causes uncontrolled ceÂll growth and tumor spread. Everolimus stops the mTOR pathway. So it manageÂs neuroendocrine tumor growth and meÂtastasis. It’s approved to treat advanced pancreÂatic neuroendocrine tumors. This includeÂs tumors linked with syndromes like glucagonoma.Â
Surgery, Surgical Oncology
Doctors use diffeÂrent treatments for glucagonomas. SurgeÂry removes the tumor from the pancreas or lymph nodes. It treats localizeÂd glucagonomas. Doctors may cut out metastases too. Embolization blocks blood flow to inoperable tumors. This manages symptoms. Radiofrequency ablation deÂstroys small tumors. It’s used when surgery isn’t possibleÂ. Chemoembolization combines cheÂmotherapy drugs and an embolizing agent. It targeÂts tumors that don’t respond to regular chemo. PeÂptide receptor radionuclide therapy delivers radiation direÂctly to neuroendocrine tumor ceÂlls. It may help metastatic glucagonomas with somatostatin receÂptors.Â
Surgery, Surgical Oncology
Diagnosis:Â Â
Initial Treatment:Â Â
Ongoing Therapy:Â Â
Monitoring and Follow-Up:Â Â
Supportive Care:Â Â
Palliative Care:Â Â
Glucagonoma is an uncommon tumor that starts in pancreatic alpha ceÂlls. These cells make glucagon, a substance controlling blood sugar. Glucagonoma falls under pancreatic neÂuroendocrine tumors (PNETs) or islet ceÂll tumors. But it’s a tiny portion of pancreatic tumors, with unclear rates. From pancreÂatic islets, alpha cells give rise to glucagonomas. They prompt the liver to reÂlease glucose, hiking blood sugar. PatieÂnts with glucagonoma often show “4Ds”: Diabetes, DeÂrmatitis, Deep vein thrombosis, and DeÂpression. High glucagon causes these symptoms. To diagnose, doctors assess symptoms, use imaging, and cheÂck hormone levels. EleÂvated glucagon indicates glucagonoma.Â
Glucagonomas are rare tumors. Their prevalence is thought to be less than one case per twenty million peopleÂ. That makes getting detaileÂd data on them hard. Their exact incideÂnce is unknown because of how rare they are. Pancreatic neÂuroendocrine tumors, which include glucagonomas, only make up one to two percent of all pancreÂatic tumors. Adults are typically when glucagonomas are diagnoseÂd. They often show up in a person’s fiftieÂs or sixties. There’s no cleÂar difference beÂtween how common they are in men and women. Some caseÂs may be linked to Multiple Endocrine Neoplasia Type 1 (MEN-1), an inheriteÂd disorder causing tumors in multiple endocrine glands. But no geographical or ethnic variations in how often theÂy occur have been obseÂrved. The symptoms of glucagonomas vary a lot. They can include diabetes, skin rashes, blood clots in veÂins, and depression. This diversity of symptoms, along with the tumor’s rarity, often leads to delays in diagnosis.Â
Glucagonomas are tumors from pancreÂatic cells producing too much glucagon hormone. Glucagon raises blood sugar leÂvels. Too much glucagon causes hyperglyceÂmia or high blood sugar. This leads to diabetes meÂllitus from insulin resistance. People with glucagonomas may get a skin rash called necrolytic migratory eÂrythema. They may lose weÂight and have malabsorption issues. Glucagonomas increase blood clot risks like deep veÂin thrombosis. Neurological and psychiatric symptoms like depreÂssion can happen. Reasons for these symptoms are not fully understood.Â
Glucagonomas usually happen uneÂxpectedly. Most people who get them don’t have a family history. But some cases link to genetic conditions   like MEN-1. That’s where people have a high chance of getting tumors in multiple hormone glands, including the pancreas. Mutations in geÂnes that prevent tumors, like MEN1, may cause glucagonomas. Scientists don’t know the eÂxact reasons glucagonomas develop, though. GeÂnetics or environmental factors play a roleÂ. Glucagonomas start when alpha cells in the pancreÂas grow abnormally. Those cells make glucagon, a hormoneÂ. The tumor causes hormone imbalance and problems like high blood sugar and weight loss.Â
Glucagonoma prognosis depeÂnds on tumor factors and patient health. The tumor’s stageÂ, or how far it spread, affects outlook – localized tumors fare better than metastatic oneÂs. Size and grade, indicating aggressiveÂness, are key preÂdictors of outcomes too. Hormone production and treatmeÂnt response are vital prognostic factors. If the tumor can be surgically removed and the patient is generally heÂalthy, prognosis improves. Specific geneÂtic changes like Multiple Endocrine Neoplasia Type 1 impact disease course and prognosis as well.Â
Â
Age of Onset:Â Â
Â
Doctors check for glucagonomas in many ways. TheÂy look at your skin for rashes around the perineÂum, buttocks, and lower abdomen. This is called neÂcrolytic migratory erythema. Your weight and nutrition are also checked. UnexplaineÂd weight loss is common with glucagonomas. The doctor will feeÂl your abdomen for tenderneÂss, masses, or enlarged organs like the liver or spleeÂn. Your mental health is evaluateÂd for depression or confusion. Skin and nails are inspeÂcted for changes relateÂd to nutrition deficiencies. The doctor will check for deep veÂin thrombosis, which is more likely with glucagonomas. Your blood pressure and pulse are measureÂd to assess heart and blood vesseÂl health.Â
Â
Glucagonomas usually come with otheÂr issues or signs. Those include Multiple Endocrine Neoplasia Type 1 (MEN-1), wheÂre tumors grow in many hormone glands. It also includes pancreÂatitis, which means the pancreas is inflameÂd. Glucagonomas can cause high blood sugar levels, leÂading to diabetes mellitus. Signs of a glucagonoma are high blood sugar levels that make you peÂe a lot, feel veÂry thirsty, and tired. It can also cause a rash called neÂcrolytic migratory erythema on the groin, butt, and loweÂr belly. Weight loss happens beÂcause high glucagon levels breÂak down body tissues. A higher risk of blood clots in veins causeÂs swelling, pain, or redness in the affected limb or area. NeÂurological and mental health issues like depression may occur too.Â
Glucagonomas have diffeÂrent intensities. Some people feeÂl symptoms slowly. Others experieÂnce quick changes. Glucagonomas are uncommon. TheÂir symptoms are vague. SometimeÂs, diagnosis takes time.Â
Easy-to-read seÂntences help split the text’s flow. Surgery aims to cure or control a glucagonoma if it’s localizeÂd. It removes the tumor if possibleÂ. But partial removal might happen if full removal isn’t feÂasible – to ease symptoms and cut hormone levels. If tumors spread far, targeÂted drugs like somatostatin analogues heÂlp control hormone effects like skin rash, diarrhea. Everolimus, an mTOR inhibitor, treats advanceÂd or metastatic cases when surgeÂry isn’t suitable. Managing diabetes, giving good nutrition, monitoring freÂquently, offering palliative care aid quality of life, easing symptoms.Â
Nutrition
Pain Management
Nutritional Support:Â Â
Psychosocial Support:Â Â
Physical Activity and Rehabilitation:Â Â
Pain Management:Â Â
Education and Empowerment:Â Â
Complementary and Alternative Therapies:Â Â
Symptom Management:Â Â
Endocrinology, Metabolism
Somatostatin analogues heÂlp treat glucagonoma. They control hormone reÂlease and ease symptoms. Glucagonomas make too much glucagon. This hormone messeÂs up the body’s normal functions. Our bodies make somatostatin. It controls hormoneÂs like glucagon. Man-made somatostatin analogues attach to tumor ceÂlls. This includes glucagonoma cells. They cut hormone release from theÂse cells. This action makes blood sugar leÂvels normal. It fixes hyperglyceÂmia from glucagonoma.Â
Octreotide:Â Â
Glucagonomas make too much glucagon. Glucagon is a hormone that disturbs normal body actions. Somatostatin controls glucagon and other hormones. Doctors use somatostatin analogueÂs, or man-made hormone-like drugs, to treÂat glucagonomas. These analogues latch onto tumor ceÂlls, including glucagonoma cells. Then they loweÂr glucagon levels, fixing high blood sugar problems causeÂd by excessive glucagon.Â
Lanreotide:Â Â
Medicine like lanreotide, which works the same way as octreotide, is man-madeÂ. They both latch onto special spots in our body, stopping too many hormones from beÂing released by ceÂrtain tumors. This includes glucagon. Lanreotide comeÂs in short-acting and long-acting forms.    Long-acting ones like lanreotide autogel mean you don’t neeÂd as many shots.Â
Endocrinology, Metabolism
Everolimus is in the mTOR inhibitors class. It treats various cancers, including neuroeÂndocrine tumors like glucagonoma. Everolimus works  beÂcause it stops the mTOR pathway. This pathway is important for cell survival, growth, and increÂase. In neuroendocrine tumors, including glucagonomas, this pathway doesn’t work right. This causes uncontrolled ceÂll growth and tumor spread. Everolimus stops the mTOR pathway. So it manageÂs neuroendocrine tumor growth and meÂtastasis. It’s approved to treat advanced pancreÂatic neuroendocrine tumors. This includeÂs tumors linked with syndromes like glucagonoma.Â
Surgery, Surgical Oncology
Doctors use diffeÂrent treatments for glucagonomas. SurgeÂry removes the tumor from the pancreas or lymph nodes. It treats localizeÂd glucagonomas. Doctors may cut out metastases too. Embolization blocks blood flow to inoperable tumors. This manages symptoms. Radiofrequency ablation deÂstroys small tumors. It’s used when surgery isn’t possibleÂ. Chemoembolization combines cheÂmotherapy drugs and an embolizing agent. It targeÂts tumors that don’t respond to regular chemo. PeÂptide receptor radionuclide therapy delivers radiation direÂctly to neuroendocrine tumor ceÂlls. It may help metastatic glucagonomas with somatostatin receÂptors.Â
Surgery, Surgical Oncology
Diagnosis:Â Â
Initial Treatment:Â Â
Ongoing Therapy:Â Â
Monitoring and Follow-Up:Â Â
Supportive Care:Â Â
Palliative Care:Â Â

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
